Astera Labs
ALAB
$350.62
-3.08%
Astera Labs designs and delivers semiconductor-based connectivity solutions for cloud and AI infrastructure, specializing in data, network, and memory management for AI-driven platforms. As a key enabler of AI infrastructure, the company has carved out a distinct competitive position by integrating semiconductor technology, microcontrollers, sensors, and software into its Intelligent Connectivity Platform, serving hyperscalers and system OEMs. The current investor narrative centers on the company's explosive growth trajectory, fueled by surging demand for AI networking hardware, its recent addition to the Nasdaq-100, and analyst optimism about its essential role in modern data centers. However, debates persist around valuation sustainability and insider selling signals, creating a tension between growth momentum and potential overextension.…
ALAB
Astera Labs
$350.62
Related headlines
ALAB 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Astera Labs's 12-month outlook, with a consensus price target around $455.81 and implied upside of +30.0% versus the current price.
Average Target
$455.81
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$281 - $456
Analyst target range
Astera Labs is covered by 7 analysts, with a consensus leaning bullish: the distribution includes 5 Buy ratings, 1 Hold, and 1 Sell, with recent upgrades from Northland Capital Markets (Outperform) and maintained Overweight ratings from JP Morgan and Morgan Stanley. The average analyst target price is not explicitly provided, but using the estimated EPS average of $8.65 and a forward P/E of 95.9x implies a target of approximately $830, representing over 100% upside from the current price of $412.97. However, this is a rough calculation; actual targets may vary. The consensus recommendation is a Buy, reflecting strong institutional confidence in the company's AI-driven growth story. The estimated EPS range is $7.60 to $11.83, and revenue estimates range from $3.67 billion to $5.20 billion, indicating a wide dispersion of expectations. The high target assumes continued market share gains and margin expansion as AI infrastructure spending accelerates, while the low target may price in competitive pressures or a slowdown in hyperscaler capex. Recent analyst actions have been predominantly positive, with upgrades and price target increases following strong earnings and product showcases. The wide spread in estimates (revenue range of $3.67B to $5.20B) signals high uncertainty about the pace of growth, which is typical for high-growth semiconductor companies. Investors should monitor quarterly results for signs of deceleration or acceleration relative to these expectations.
ALAB Technical Analysis
Astera Labs is in a powerful long-term uptrend, with the stock surging 325.65% over the past year and currently trading at 82.7% of its 52-week range (current price $412.97 vs. 52-week high of $499.476 and low of $88.185). This positioning near the top of the range reflects strong momentum and investor enthusiasm, though it also suggests the stock may be overextended in the near term. The 1-year price change of 325.65% dramatically outpaces the SPY's 20.63% gain, highlighting the stock's exceptional relative strength. Short-term momentum remains robust but shows signs of deceleration: the 1-month price change is +24.82%, while the 3-month change is +177.07%, indicating that the pace of gains has moderated recently. This divergence between the explosive 3-month rally and the more tempered 1-month move could signal a consolidation phase or a temporary pullback, especially as the stock has pulled back from its June 30 close of $483.02 to $412.97. The beta of 3.671 indicates the stock is 267% more volatile than the S&P 500, amplifying both upside and downside moves. Key support lies near the 52-week low of $88.185, but a more immediate floor may form around the $320 area (May 26 close). Resistance is at the 52-week high of $499.476; a breakout above that level would signal renewed momentum and potentially target higher, while a breakdown below $320 could indicate a deeper correction. Given the extreme beta, position sizing should account for significant daily swings.
Beta
3.67
3.67x market volatility
Max Drawdown
-60.2%
Largest decline past year
52-Week Range
$89-$499
Price range past year
Annual Return
+279.6%
Cumulative gain past year
| Period | ALAB Return | S&P 500 |
|---|---|---|
| 1m | -9.9% | +0.0% |
| 3m | +105.3% | +7.6% |
| 6m | +92.6% | +9.1% |
| 1y | +279.6% | +21.3% |
| ytd | +95.3% | +10.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ALAB Fundamental Analysis
Astera Labs is experiencing explosive revenue growth, with Q4 2025 revenue of $270.6 million representing 91.77% year-over-year growth, accelerating from the prior year's Q4 2024 revenue of $141.1 million. The sequential trend is equally impressive: revenue has grown from $65.3 million in Q1 2024 to $270.6 million in Q4 2025, a compound quarterly growth rate of approximately 42%. This growth is driven by the company's AI connectivity solutions, which are critical for hyperscale data centers. The company has achieved profitability, with Q4 2025 net income of $45.0 million and a net margin of 16.6%, a dramatic improvement from a net loss of $93.0 million in Q1 2024. Gross margins are exceptionally high at 75.6% in Q4 2025, consistent with the semiconductor industry's asset-light model, and have remained stable around 74-78% over the past eight quarters. Operating margins have expanded from -127% in Q1 2024 to 24.7% in Q4 2025, demonstrating strong operating leverage as revenue scales. The balance sheet is fortress-like: the company has a current ratio of 10.24, a debt-to-equity ratio of just 0.026, and generated $95.3 million in operating cash flow and $76.6 million in free cash flow in Q4 2025. Free cash flow for the trailing twelve months is $281.8 million, providing ample internal funding for growth. Return on equity (ROE) stands at 16.1%, reflecting efficient capital use, while the debt-free balance sheet minimizes financial risk. The company's cash position of $167.6 million and negligible debt provide significant liquidity to weather any downturns or invest in expansion.
Quarterly Revenue
$270583000.0B
2025-12
Revenue YoY Growth
+91.8%
YoY Comparison
Gross Margin
75.6%
Latest Quarter
Free Cash Flow
$281762000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ALAB Overvalued?
Since net income is positive ($45.0 million in Q4 2025), the P/E ratio is the primary valuation metric. The trailing P/E is 126.0x, while the forward P/E is 95.9x, implying the market expects earnings to grow by approximately 24% over the next year. The gap between trailing and forward P/E suggests that while the stock is expensive on current earnings, investors are pricing in continued strong earnings growth. Compared to the semiconductor industry average P/E of roughly 22x, Astera Labs trades at a 473% premium, reflecting its exceptional growth rate and market position. The P/S ratio of 32.5x and EV/Sales of 70.3x further underscore the premium valuation, which is justified by the company's 92% revenue growth and expanding margins. Historically, the stock's P/E has ranged from a low of around 73x (Q2 2025) to a high of 214x (Q4 2024), with the current trailing P/E of 126x sitting near the middle of that range. This suggests that while the stock is not at its cheapest, it is also not at the extreme highs seen in late 2024, indicating that the market's growth expectations have moderated somewhat but remain optimistic. The PEG ratio of -0.41 is not meaningful due to negative earnings growth in the trailing period, but the forward PEG based on analyst estimates would be approximately 1.2x (95.9x P/E divided by ~80% expected EPS growth), which is more reasonable for a high-growth company.
PE
126.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -757x~214x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
122.5x
Enterprise Value Multiple

